These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Characterization of lidocaine-specific T cells. Zanni MP, Mauri-Hellweg D, Brander C, Wendland T, Schnyder B, Frei E, von Greyerz S, Bircher A, Pichler WJ. J Immunol; 1997 Feb 01; 158(3):1139-48. PubMed ID: 9013953 [Abstract] [Full Text] [Related]
24. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Panina-Bordignon P, Tan A, Termijtelen A, Demotz S, Corradin G, Lanzavecchia A. Eur J Immunol; 1989 Dec 01; 19(12):2237-42. PubMed ID: 2481588 [Abstract] [Full Text] [Related]
26. Antigen-specific and polyclonal immunoglobulin production induced by a cloned tetanus toxoid-specific T cell line. Friedman SM, Principato MA, Thompson GS, Teichman F. J Immunol; 1983 Mar 01; 130(3):1164-70. PubMed ID: 6185573 [Abstract] [Full Text] [Related]
27. Classification of CD4+ T helper cell clones in human melanoma. Goedegebuure PS, Lee KY, Matory YL, Peoples GE, Yoshino I, Eberlein TJ. Cell Immunol; 1994 Jun 01; 156(1):170-9. PubMed ID: 7911074 [Abstract] [Full Text] [Related]
28. Immune selection in murine tumors. Ph.d thesis. Svane IM, Engel AM. APMIS Suppl; 2003 Jun 01; (106):1-46. PubMed ID: 12739251 [Abstract] [Full Text] [Related]
29. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2. Dennig D, Yan Y, Ferguson K, O'Reilly RJ. Cell Immunol; 1996 Aug 01; 171(2):200-10. PubMed ID: 8806788 [Abstract] [Full Text] [Related]
30. Purified HLA class II peptide complexes can induce adherence and activation of peptide-specific human T cell clones. van Schooten WC, Maiore T, Jones KR, Paborsky L. J Immunol; 1992 Feb 15; 148(4):1043-8. PubMed ID: 1531349 [Abstract] [Full Text] [Related]
31. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. Gajewski TF, Pinnas M, Wong T, Fitch FW. J Immunol; 1991 Mar 15; 146(6):1750-8. PubMed ID: 1826010 [Abstract] [Full Text] [Related]
34. Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes. Umetsu DT, Katzen D, Jabara HH, Geha RS. J Immunol; 1986 Jan 15; 136(2):440-5. PubMed ID: 3484491 [Abstract] [Full Text] [Related]
35. Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Jacquier-Sarlin MR, Gabert FM, Villiers MB, Colomb MG. Immunology; 1995 Jan 15; 84(1):164-70. PubMed ID: 7890301 [Abstract] [Full Text] [Related]
36. HLA class I and II molecules present influenza virus antigens with different kinetics. Kuijpers KC, van Kemenade FJ, Hooibrink B, Neefjes JJ, Lucas CJ, van Lier RA, Miedema F. Eur J Immunol; 1992 Sep 15; 22(9):2339-45. PubMed ID: 1516624 [Abstract] [Full Text] [Related]
37. T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen and autoantigen. LaSalle JM, Toneguzzo F, Saadeh M, Golan DE, Taber R, Hafler DA. J Immunol; 1993 Jul 15; 151(2):649-57. PubMed ID: 7687620 [Abstract] [Full Text] [Related]
38. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1. Chu ET, Lareau M, Rosenwasser LJ, Dinarello CA, Geha RS. J Immunol; 1985 Mar 15; 134(3):1676-81. PubMed ID: 2981918 [Abstract] [Full Text] [Related]
39. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. J Immunol; 1993 Jan 15; 150(2):353-60. PubMed ID: 8419468 [Abstract] [Full Text] [Related]
40. Phenotype and cytokine profile of Schistosoma mansoni specific T cell lines and clones derived from schistosomiasis patients with distinct clinical forms. Contigli C, Silva-Teixeira DN, Del Prete G, D'Elios MM, De Carli M, Manghetti M, Amedei A, Almerigogna F, Lambertucci JR, Goes AM. Clin Immunol; 1999 Jun 15; 91(3):338-44. PubMed ID: 10370380 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]